Trimosulfa | CAS#8064-90-2 | antibiotic combination

Trimosulfa
featured

WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 562211

CAS#: 8064-90-2

Description: Trimosulfa is a fixed antibiotic combination. It is widely used for mild-to-moderate bacterial infections and as prophylaxis against opportunistic infections.

Chemical Structure

Trimosulfa

CAS# 8064-90-2

Instruction

Theoretical Analysis

MedKoo Cat#: 562211
Name: Trimosulfa
CAS#: 8064-90-2
Chemical Formula: C24H29N7O6S
Exact Mass: 543.19
Molecular Weight: 543.590
Elemental Analysis: C, 53.03; H, 5.38; N, 18.04; O, 17.66; S, 5.90

Price and Availability

Size	Price	Availability	Quantity
100mg	USD 600
Bulk inquiry Welcome, Customer: Please do not inquire quote if your intended use is for a patient since our products are for research use and for chemical synthesis use, not for human use . For in-stock products, we listed price in the web page. You may inquire prices for which sizes were not listed. If no price is listed, this means the product is not in stock at the moment, which may be available via custom synthesis. For cost-effective reason, minimum order of 1g is requested (typically very expensive). The lead time is usually 2-4 months. Quote of less than 1g will not be provided. MedKoo may not offer quote for below reasons: (1) current available synthetic method appears to be extremely expensive which is obviously not affordable to most customers; (2) Key raw material to make the product is temporally not available; (3) DEA controlled substances; (4) the product is under patent protection in customer’s country.

Synonym: Trimosulfa; Trimethoprimsulfa; Trimethoprim-sulfamethoxazole; Trimforte; Sulfamethoxazole-trimethoprim; TMP-SMX;

IUPAC/Chemical Name: 4-amino-N-(5-methylisoxazol-3-yl)benzenesulfonamide compound with 5-(3,4,5-trimethoxybenzyl)pyrimidine-2,4-diamine (1:1)

InChi Key: WZRJTRPJURQBRM-UHFFFAOYSA-N

InChi Code: InChI=1S/C14H18N4O3.C10H11N3O3S/c1-19-10-5-8(6-11(20-2)12(10)21-3)4-9-7-17-14(16)18-13(9)15;1-7-6-10(12-16-7)13-17(14,15)9-4-2-8(11)3-5-9/h5-7H,4H2,1-3H3,(H4,15,16,17,18);2-6H,11H2,1H3,(H,12,13)

SMILES Code: O=S(C1=CC=C(N)C=C1)(NC2=NOC(C)=C2)=O.COC3=C(OC)C(OC)=CC(CC4=C(N)N=C(N)N=C4)=C3

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Instruction:

View handling instruction

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 543.59 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.

Mass

Concentration

Volume

M. Wt* g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

Volume (to add to vial)

Mass (in vial)

Desired Reconstitution Concentration

Dilution Calculator

Calculate the dilution required to prepare a stock solution.

Concentration 1

Volume 1

Concentration 2

Volume 2

1: Zunza M, Gray DM, Young T, Cotton M, Zar HJ. Isoniazid for preventing tuberculosis in HIV-infected children. Cochrane Database Syst Rev. 2017 Aug 29;8:CD006418. doi: 10.1002/14651858.CD006418.pub3. Review. PubMed PMID: 28850172; PubMed Central PMCID: PMC5618450.

2: Ruzagira E, Baisley K, Kamali A, Biraro S, Grosskurth H; Working Group on Linkage to HIV Care. Linkage to HIV care after home-based HIV counselling and testing in sub-Saharan Africa: a systematic review. Trop Med Int Health. 2017 Jul;22(7):807-821. doi: 10.1111/tmi.12888. Epub 2017 May 22. Review. PubMed PMID: 28449385.

3: Cherazard R, Epstein M, Doan TL, Salim T, Bharti S, Smith MA. Antimicrobial Resistant Streptococcus pneumoniae: Prevalence, Mechanisms, and Clinical Implications. Am J Ther. 2017 May;24(3):e361-e369. doi: 10.1097/MJT.0000000000000551. Review. PubMed PMID: 28430673.

4: Seng P, Amrane S, Million M, Stein A. Old antimicrobials and Gram-positive cocci through the example of infective endocarditis and bone and joint infections. Int J Antimicrob Agents. 2017 May;49(5):558-564. doi: 10.1016/j.ijantimicag.2017.03.004. Epub 2017 Mar 29. Review. PubMed PMID: 28365430.

5: Pichler WJ, Srinoulprasert Y, Yun J, Hausmann O. Multiple Drug Hypersensitivity. Int Arch Allergy Immunol. 2017;172(3):129-138. doi: 10.1159/000458725. Epub 2017 Mar 18. Review. PubMed PMID: 28315874; PubMed Central PMCID: PMC5472211.

6: White PL, Backx M, Barnes RA. Diagnosis and management of Pneumocystis jirovecii infection. Expert Rev Anti Infect Ther. 2017 May;15(5):435-447. doi: 10.1080/14787210.2017.1305887. Epub 2017 Mar 20. Review. PubMed PMID: 28287010.

7: Bienenfeld A, Nagler AR, Orlow SJ. Oral Antibacterial Therapy for Acne Vulgaris: An Evidence-Based Review. Am J Clin Dermatol. 2017 Aug;18(4):469-490. doi: 10.1007/s40257-017-0267-z. Review. PubMed PMID: 28255924.

8: Feldman C, Anderson R, Rossouw T. HIV-related pneumococcal disease prevention in adults. Expert Rev Respir Med. 2017 Mar;11(3):181-199. doi: 10.1080/17476348.2017.1289841. Epub 2017 Feb 21. Review. PubMed PMID: 28228053.

9: Zayyad H, Eliakim-Raz N, Leibovici L, Paul M. Revival of old antibiotics: needs, the state of evidence and expectations. Int J Antimicrob Agents. 2017 May;49(5):536-541. doi: 10.1016/j.ijantimicag.2016.11.021. Epub 2017 Feb 2. Review. PubMed PMID: 28162982.

10: Kaye KS, Gales AC, Dubourg G. Old antibiotics for multidrug-resistant pathogens: from in vitro activity to clinical outcomes. Int J Antimicrob Agents. 2017 May;49(5):542-548. doi: 10.1016/j.ijantimicag.2016.11.020. Epub 2017 Jan 24. Review. PubMed PMID: 28130072.

11: Messiaen PE, Cuyx S, Dejagere T, van der Hilst JC. The role of CD4 cell count as discriminatory measure to guide chemoprophylaxis against Pneumocystis jirovecii pneumonia in human immunodeficiency virus-negative immunocompromised patients: A systematic review. Transpl Infect Dis. 2017 Apr;19(2). doi: 10.1111/tid.12651. Epub 2017 Feb 15. Review. PubMed PMID: 28035717.

12: Biagi F, Biagi GL, Corazza GR. What is the best therapy for Whipple's disease? Our point of view. Scand J Gastroenterol. 2017 Apr;52(4):465-466. doi: 10.1080/00365521.2016.1264009. Epub 2016 Dec 7. Review. PubMed PMID: 27924649.

13: Ishikawa S, Watanabe T, Iino M. Acute septic arthritis of the temporomandibular joint derived from otitis media: a report and review of the English and Japanese literature. Oral Maxillofac Surg. 2017 Mar;21(1):83-85. doi: 10.1007/s10006-016-0604-z. Epub 2016 Dec 5. Review. PubMed PMID: 27917456.

14: Ezzedine K. [What's new in dermatological therapy?]. Ann Dermatol Venereol. 2016 Dec;143 Suppl 3:S37-S42. doi: 10.1016/S0151-9638(18)30048-6. Review. French. PubMed PMID: 29429508.

15: Baker R, Seamon J. BET 1: Trimethoprim-sulfamethoxazole in uncomplicated skin abscess. Emerg Med J. 2016 Dec;33(12):891-892. doi: 10.1136/emermed-2016-206440.1. Review. PubMed PMID: 27864392.

16: Li H, Huang H, He H. Successful treatment of severe Pneumocystis pneumonia in an immunosuppressed patient using caspofungin combined with clindamycin: a case report and literature review. BMC Pulm Med. 2016 Nov 11;16(1):144. Review. PubMed PMID: 27835947; PubMed Central PMCID: PMC5106782.

17: Nakamura I, Nagakura T, Fujita H, Fukusima S, Gonoi T. Nocardia elegans infection: a case report and literature review. Int J Infect Dis. 2017 Jan;54:15-17. doi: 10.1016/j.ijid.2016.10.031. Epub 2016 Nov 5. Review. PubMed PMID: 27826114.

18: Price JR, Guran LA, Gregory WT, McDonagh MS. Nitrofurantoin vs other prophylactic agents in reducing recurrent urinary tract infections in adult women: a systematic review and meta-analysis. Am J Obstet Gynecol. 2016 Nov;215(5):548-560. doi: 10.1016/j.ajog.2016.07.040. Epub 2016 Jul 22. Review. PubMed PMID: 27457111.

19: Hernandez AV, Thota P, Pellegrino D, Pasupuleti V, Benites-Zapata VA, Deshpande A, Penalva de Oliveira AC, Vidal JE. A systematic review and meta-analysis of the relative efficacy and safety of treatment regimens for HIV-associated cerebral toxoplasmosis: is trimethoprim-sulfamethoxazole a real option? HIV Med. 2017 Feb;18(2):115-124. doi: 10.1111/hiv.12402. Epub 2016 Jun 28. Review. PubMed PMID: 27353303.

20: Tattevin P, Mainardi JL. Analysis of the 2015 American and European guidelines for the management of infective endocarditis. Med Mal Infect. 2016 Dec;46(8):406-410. doi: 10.1016/j.medmal.2016.05.008. Epub 2016 Jun 11. Review. PubMed PMID: 27297743.

Your view history

Trimosulfa featured